| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | NPG3 |
| Uniprot No | P56975 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 282-342aa |
| 氨基酸序列 | ERSEHFKPCR DKDLAYCLND GECFVIETLT GSHKHCRCKE GYQGVRCDQF LPKTDSILSD P |
| 预测分子量 | 34 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下为假设性示例参考文献(注：NPG3重组蛋白相关研究在真实文献中可能不存在，以下内容仅供格式参考)：
1. **《重组NPG3蛋白的制备及其在细胞凋亡调控中的作用》**
作者：Zhang L, et al.
摘要：本研究通过原核表达系统成功纯化重组NPG3蛋白，并证实其通过调控Bcl-2/Bax通路抑制肿瘤细胞凋亡，为癌症治疗提供潜在靶点。
2. **《NPG3重组蛋白的晶体结构解析与功能域分析》**
作者：Wang Y, et al.
摘要：利用X射线衍射技术解析了NPG3重组蛋白的三维结构，揭示其C端结构域在DNA结合中的关键作用，为设计靶向抑制剂奠定基础。
3. **《NPG3重组蛋白在神经退行性疾病中的炎症调节功能》**
作者：Smith J, et al.
摘要：实验表明，重组NPG3蛋白可抑制小胶质细胞中NF-κB信号通路，减轻阿尔茨海默病模型小鼠的神经炎症反应。
4. **《高效表达NPG3重组蛋白的毕赤酵母系统构建》**
作者：Chen H, et al.
摘要：优化毕赤酵母表达体系实现NPG3蛋白的高效分泌表达，产物具备天然活性，适用于大规模生产及抗体开发。
(提示：以上内容为模拟示例，实际文献需通过PubMed、Web of Science等学术平台检索确认。)
NPG3 recombinant protein is a engineered biomolecule developed for applications in biomedical research and therapeutic interventions. As a recombinant protein, it is produced through genetic engineering techniques, where the gene encoding the target protein is inserted into a host organism (e.g., bacteria, yeast, or mammalian cells) to enable large-scale production. The "NPG3" designation typically reflects its functional or structural characteristics, though specific nomenclature may vary by research context.
This protein is often designed to mimic or enhance natural biological activities, such as cell signaling, immune modulation, or molecular binding. Its recombinant nature ensures high purity, consistency, and scalability compared to proteins isolated from natural sources. NPG3 may incorporate tags (e.g., His-tag, FLAG-tag) for simplified purification or detection.
In research, NPG3 is utilized to study protein-protein interactions, receptor-ligand dynamics, or pathways relevant to diseases like cancer, autoimmune disorders, or infectious diseases. Therapeutically, recombinant proteins like NPG3 hold promise as biologics due to their specificity and reduced immunogenicity risks when humanized.
Advances in expression systems (e.g., CHO cells for post-translational modifications) and bioprocessing technologies have optimized NPG3’s production. Challenges include maintaining structural integrity and functionality during scale-up. Ongoing studies focus on improving stability, delivery mechanisms, and cost-effectiveness for clinical translation.
Overall, NPG3 exemplifies the intersection of biotechnology and medicine, offering tools for both mechanistic exploration and next-generation therapies. Its development aligns with the growing emphasis on precision medicine and targeted treatments.
×
